Christine Ring

Chief Legal Officer, Nurix Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.4M

Companies

Latest trade

Oct 2, 2026

Companies

Nurix Therapeutics, Inc.Chief Legal Officer −$3.4M

Trades

NRIX Sold 5,786 shares at $23.19 · planned $0.1M Oct 2

NRIX Sold 5,787 shares at $25.76 · planned $0.1M Sep 2

NRIX Sold 16,589 shares at $23.05 · planned $0.4M Aug 3

NRIX Sold 3,847 shares at $23.38 $0.1M Jul 30

NRIX Sold 11,008 shares at $23.56 · planned $0.3M Jul 2

NRIX Sold 28,935 shares at $20.06 · planned $0.6M Jun 25

NRIX Sold 8,148 shares at $16.60 · planned $0.1M Jun 2

NRIX Sold 8,148 shares at $16.96 · planned $0.1M May 4

NRIX Sold 5,394 shares at $16.76 · planned $0.1M May 1

NRIX Sold 3,214 shares at $16.65 $0.1M Apr 30

NRIX Sold 8,148 shares at $15.24 · planned $0.1M Apr 2

NRIX Sold 8,148 shares at $15.44 · planned $0.1M Mar 2

NRIX Sold 14,261 shares at $16.66 · planned $0.2M Feb 9

NRIX Sold 4,421 shares at $16.60 $0.1M Jan 30

NRIX Sold 3,760 shares at $18.42 · planned $0.1M Jan 20

NRIX Sold 3,760 shares at $17.91 · planned $0.1M Dec 18

NRIX Sold 37,600 shares at $17.07 · planned $0.6M Nov 24

NRIX Sold 3,644 shares at $12.80 $0.0M Oct 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.